We are live on ! Find out more
VCYT icon

Veracyte

179 hedge funds and large institutions have $1.48B invested in Veracyte in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.64M | Put options by funds: $422K

16% more capital invested

Capital invested by funds: $1.28B → $1.48B (+$200M)

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

1.5% less ownership

Funds ownership: 109.82%108.32% (-1.5%)

4% less funds holding

Funds holding: 187179 (-8)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
179
Holders Change
-8
Holders Change %
-4.28%
% of All Funds
3.53%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
31
Increased
55
Reduced
69
Closed
32
Calls
$1.64M
Puts
$422K
Net Calls
+$1.22M
Net Calls Change
+$1.62M
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
$1.77M +$113K +4,351 +7%
Citigroup
77
Citigroup
New York
$1.53M -$343K -13,248 -19%
Rafferty Asset Management
78
Rafferty Asset Management
New York
$1.52M -$1.64M -63,170 -54%
KOCAA
79
Knights of Columbus Asset Advisors
Connecticut
$1.51M +$1.4M +54,066 New
MAG
80
Millrace Asset Group
Pennsylvania
$1.5M -$814K -31,460 -37%
Barclays
81
Barclays
United Kingdom
$1.4M +$431K +16,650 +50%
FPC
82
Falcon Point Capital
California
$1.39M -$579K -22,376 -31%
American Century Companies
83
American Century Companies
Missouri
$1.34M -$1.71M -65,950 -58%
William Blair & Company
84
William Blair & Company
Illinois
$1.25M +$514K +19,863 +80%
Deutsche Bank
85
Deutsche Bank
Germany
$1.25M -$4.14M -159,902 -78%
Qube Research & Technologies (QRT)
86
Qube Research & Technologies (QRT)
United Kingdom
$1.14M +$1.06M +40,990 New
UBS AM
87
UBS AM
Illinois
$1.12M +$84.7K +3,273 +9%
Norges Bank
88
Norges Bank
Norway
$1.12M
Principal Financial Group
89
Principal Financial Group
Iowa
$1.07M +$431K +16,643 +77%
PAM
90
Panagora Asset Management
Massachusetts
$973K +$19.5K +754 +2%
Assenagon Asset Management
91
Assenagon Asset Management
Luxembourg
$958K +$888K +34,298 New
SEI Investments
92
SEI Investments
Pennsylvania
$864K -$950K -36,709 -54%
SO
93
STRS Ohio
Ohio
$857K -$54.4K -2,100 -6%
AIG
94
American International Group
New York
$825K -$6.42K -248 -0.8%
Envestnet Asset Management
95
Envestnet Asset Management
Illinois
$823K +$174K +6,707 +29%
Manulife (Manufacturers Life Insurance)
96
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$788K -$19.1K -737 -3%
Skandinaviska Enskilda Banken (SEB)
97
Skandinaviska Enskilda Banken (SEB)
Sweden
$734K +$681K +26,300 New
AIA
98
Affinity Investment Advisors
California
$728K
GPGA
99
Grandeur Peak Global Advisors
Utah
$723K -$109K -4,225 -14%
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$722K +$10.4K +402 +2%

VCYT Hedge Fund Activity: Q4 2019 in Review

179 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2019, worth a combined $1.48B — up 16% from $1.28B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of VCYT and 31 opened new positions — a net loss of 1 holder — while 69 trimmed existing stakes and 55 added.

The largest buyer was Artisan Partners, adding an estimated $39.2M. The largest seller was Nuveen, cutting an estimated $14.8M.

  • 179 institutional investors held Veracyte (VCYT) as of Q4 2019, down from 187 in Q3 2019.
  • Funds reported $1.48B of Veracyte stock for Q4 2019, up 16% quarter-over-quarter.
  • 31 funds opened new Veracyte positions in Q4 2019 and 32 closed out, a net change of -1 holder.
  • The largest Veracyte buyer in Q4 2019 was Artisan Partners, an estimated $39.2M added.
  • The largest Veracyte seller in Q4 2019 was Nuveen, an estimated $14.8M sold.

Based on aggregated 13F filings for Q4 2019.